Brixadi (buprenorphine) Subcutaneous Injection, 8 mg Weekly Prefilled Syringe, 0.16 mL, Each
Brixadi is a brand-name buprenorphine extended-release subcutaneous injection indicated for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers 8 mg of buprenorphine in a 0.16 mL volume for weekly administration, providing a convenient, once-weekly dosing option. It is intended for use in a clinical setting under the supervision of a healthcare professional.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Brixadi is a brand-name buprenorphine extended-release subcutaneous injection indicated for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers 8 mg of buprenorphine in a 0.16 mL volume for weekly administration, providing a convenient, once-weekly dosing option. It is intended for use in a clinical setting under the supervision of a healthcare professional.
1 vendor
